Engineered Aurotherapy for the Multimodal Treatment of Glioblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Engineered Aurotherapy for the Multimodal Treatment of Glioblastoma

Published:2022 Issue:4 Volume:10 Page:215
ISSN:2288-2405
Container-title:Brain Tumor Research and Treatment
language:en
Short-container-title:Brain Tumor Res Treat

Author:

Kim Hyung Shik¹^ORCID,Lee Dong Yun¹²³^ORCID

Affiliation:

1. Department of Bioengineering, College of Engineering, and BK FOUR Biopharmaceutical Innovation Leader for Education and Research Group, Hanyang University, Seoul, Korea.

2. Institute of Nano Science and Technology (INST) & Institute for Bioengineering and Biopharmaceutical Research (IBBR), Hanyang University, Seoul, Korea.

3. Elixir Pharmatech Inc., Seoul, Korea.

Funder

National Research Foundation of Korea

Publisher

The Korean Brain Tumor Society, The Korean Society for Neuro-Oncology

Subject

General Earth and Planetary Sciences,General Engineering,General Environmental Science

Link

https://btrt.org/pdf/10.14791/btrt.2022.0032

Reference53 articles.

1. Recent advances in the molecular understanding of glioblastoma

2. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

3. Long-term survival with glioblastoma multiforme

4. Surgery for Glioblastoma Multiforme: Striking a Balance

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP